D384DRG Cardia DR
Implantable Cardioverter Defibrillator (ICD)
D384DRG Cardia DR
Information

Device Survival Probability

D3xxDRx_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr 12 yr at 147.0 mo                
% Excluding Normal Battery Depletion 100.0 99.9 99.9 99.9 99.9 99.8 99.7 99.7 99.6 99.6 99.6 99.6 99.6                
% Including Normal Battery Depletion 99.8 99.7 99.5 99.0 97.2 91.3 77.7 53.0 39.0 37.4 36.9 36.7 36.7                
#   54185 50301 46253 42262 37892 31014 20480 9398 5321 4618 3945 1133 266                
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

  • There are no communications for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-DDDR
Max. Delivered Energy 35 J
More
Connector Style DR Style
Serial Number Prefix PXF
Mass 68 g
Volume 37 cc
Waveform Biphasic
X-Ray ID PSI
Hide this content
DR Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.6 4.1 4.5 4.7
Quarterly 5.1 6.0 7.0 7.5
Semi-annual 5.7 7.0 8.3 9.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release
CE Approval Date2011-01-12
Registered USA Implants
Estimated Active USA Implants
Normal Battery Depletions
US Market Release
CE Approval Date2011-01-12
Estimated WW Distribution7778
Normal Battery Depletions2
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 4
Electrical Component 4
Therapy Function Compromised 3
Battery 3
Information

EOL Indicator

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.63V on 3 consecutive daily automatic measurments.

Information

Charge Time

D264DRG_D284DRG_D384DRx_D394DRx_CHRG
Loading...

Data as of November 20, 2024

www.medtronic.com/productperformance 1026050